Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP909529.RA3fpUY9zwPxM694oo41qLNHfy_ukaJpfhNuBLymb-lFk130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP909529.RA3fpUY9zwPxM694oo41qLNHfy_ukaJpfhNuBLymb-lFk130_assertion type Assertion NP909529.RA3fpUY9zwPxM694oo41qLNHfy_ukaJpfhNuBLymb-lFk130_head.
- NP909529.RA3fpUY9zwPxM694oo41qLNHfy_ukaJpfhNuBLymb-lFk130_assertion description "[A total of 232 serum and plasma samples derived from patients with chronic hepatitis C (genotype 1 [GT1], n = 108; GT2, n = 8; GT3, n = 24; GT4, n = 87; GT5, n = 3; and GT6, n = 2) were processed in parallel with the Cobas AmpliPrep/Cobas TaqMan HCV Test (CAP/CTM), Cobas Amplicor HCV Monitor Test v2.0 (CAM), and two second-version prototype formulations of CAP/CTM, Mastermix 1 (MMx1) and MMx2.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP909529.RA3fpUY9zwPxM694oo41qLNHfy_ukaJpfhNuBLymb-lFk130_provenance.
- NP909529.RA3fpUY9zwPxM694oo41qLNHfy_ukaJpfhNuBLymb-lFk130_assertion evidence source_evidence_literature NP909529.RA3fpUY9zwPxM694oo41qLNHfy_ukaJpfhNuBLymb-lFk130_provenance.
- NP909529.RA3fpUY9zwPxM694oo41qLNHfy_ukaJpfhNuBLymb-lFk130_assertion SIO_000772 21752967 NP909529.RA3fpUY9zwPxM694oo41qLNHfy_ukaJpfhNuBLymb-lFk130_provenance.
- NP909529.RA3fpUY9zwPxM694oo41qLNHfy_ukaJpfhNuBLymb-lFk130_assertion wasDerivedFrom befree-2016 NP909529.RA3fpUY9zwPxM694oo41qLNHfy_ukaJpfhNuBLymb-lFk130_provenance.
- NP909529.RA3fpUY9zwPxM694oo41qLNHfy_ukaJpfhNuBLymb-lFk130_assertion wasGeneratedBy ECO_0000203 NP909529.RA3fpUY9zwPxM694oo41qLNHfy_ukaJpfhNuBLymb-lFk130_provenance.